SevenBridge Financial Group LLC Buys 2,511 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• SevenBridge Financial Group LLC increased its stake in Intuitive Surgical by 46.2%, purchasing 2,511 shares to hold 7,944 shares valued at about $3.55 million at the end of the quarter.
• Market views are mixed: several analyst upgrades (including Citi to Buy and an average price target near $616) and catalysts like da Vinci 5 adoption and distribution acquisitions support upside, while recent insider sales, management's warning of slower procedure growth in 2026, and a rich valuation (P/E ~62) temper near-term expectations.

SevenBridge Financial Group LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 46.2% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,944 shares of the medical equipment provider's stock after purchasing an additional 2,511 shares during the quarter. SevenBridge Financial Group LLC's holdings in Intuitive Surgical were worth $3,553,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brighton Jones LLC boosted its position in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after acquiring an additional 731 shares during the period. Sivia Capital Partners LLC grew its stake in Intuitive Surgical by 3.8% during the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider's stock valued at $504,000 after acquiring an additional 34 shares in the last quarter. Schnieders Capital Management LLC. increased its holdings in Intuitive Surgical by 38.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider's stock worth $529,000 after acquiring an additional 268 shares during the period. Illinois Municipal Retirement Fund lifted its stake in Intuitive Surgical by 8.8% in the 2nd quarter. Illinois Municipal Retirement Fund now owns 11,933 shares of the medical equipment provider's stock worth $6,485,000 after purchasing an additional 968 shares in the last quarter. Finally, CENTRAL TRUST Co lifted its stake in Intuitive Surgical by 5.1% in the 2nd quarter. CENTRAL TRUST Co now owns 2,828 shares of the medical equipment provider's stock worth $1,537,000 after purchasing an additional 137 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Citi upgraded ISRG from Neutral to Buy with a $590 price target, signaling renewed Wall Street conviction and likely driving buying interest. Intuitive Surgical Upgraded to Buy by Citi — Plus Key Moves on Stryker and Abbott
• Positive Sentiment: Analyst and sector commentary highlight long-term growth from da Vinci 5 adoption and the broader robotic surgery market, supporting upside expectations. Intuitive Surgical: The Robotic Surgery Leader Still Has Massive Growth Ahead
• Positive Sentiment: Analysts point to da Vinci 5 momentum and continued procedure volume expansion (plus Ion and SP platform contributions) as drivers for recurring revenue growth into 2026. Intuitive Surgical Poised for Growth in 2026 on da Vinci 5 Momentum
• Positive Sentiment: ISRG completed the acquisition of several regional da Vinci and Ion distribution businesses, simplifying channels and potentially improving margins/recurring revenue capture. Intuitive Surgical Announces Completion of Acquisition of da Vinci and Ion Distribution Business
• Neutral Sentiment: Market commentary notes ISRG outperformed peers on a strong trading day, but without a single clear catalyst — short-term moves appear market- and sentiment-driven. Intuitive Surgical Inc. stock outperforms competitors on strong trading day
• Neutral Sentiment: Valuation analyses (and some sell‑side notes) show mixed returns: strong fundamentals and long-term returns versus recent momentum loss; this leaves the stock in a “growth at a premium” category. Assessing Intuitive Surgical (ISRG) Valuation As Shares Tread Water Despite Growth
• Negative Sentiment: Insider sales: several recent senior-exec stock sales (SVP Mark Brosius and EVP Myriam Curet among others) add selling pressure and raise short-term sentiment concerns. SEC Filing — Insider Sales
• Negative Sentiment: Management warned of a notable deceleration in worldwide da Vinci procedure growth for 2026, which could temper revenue/procedure growth expectations in the near term. Intuitive Surgical Stock: Buy, Sell, or Hold?
• Negative Sentiment: Valuation remains rich (P/E ~63 vs. historical average ~53.5), supporting cautious/hold views from some analysts despite strong margins and cash on the balance sheet. Intuitive Surgical - Strong Moat But Valuation Remains Elevated, Hold

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, SVP Patricia L. Wadors sold 220 shares of the stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $499.71, for a total transaction of $109,936.20. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Fredrik Widman sold 133 shares of the business's stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the sale, the vice president owned 660 shares of the company's stock, valued at approximately $326,673.60. The trade was a 16.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 37,907 shares of company stock worth $19,997,187. 0.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Evercore reduced their price target on shares of Intuitive Surgical from $580.00 to $550.00 and set an "in-line" rating for the company in a research report on Friday, January 23rd. Zacks Research upgraded Intuitive Surgical from a "hold" rating to a "strong-buy" rating in a research report on Thursday, February 19th. BTIG Research reissued a "buy" rating and set a $616.00 price objective on shares of Intuitive Surgical in a research note on Friday, January 23rd. The Goldman Sachs Group restated a "buy" rating and set a $714.00 target price on shares of Intuitive Surgical in a research report on Friday, January 9th. Finally, Wall Street Zen lowered Intuitive Surgical from a "buy" rating to a "hold" rating in a research note on Saturday, February 7th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average price target of $615.86.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $492.87 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $603.88. The company has a fifty day moving average of $516.79 and a 200-day moving average of $512.60. The company has a market capitalization of $175.03 billion, a P/E ratio of 62.47, a P/E/G ratio of 3.75 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts' consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business had revenue of $2.87 billion for the quarter, compared to analysts' expectations of $2.72 billion. During the same quarter in the prior year, the firm earned $2.21 earnings per share. The firm's revenue was up 18.8% on a year-over-year basis. As a group, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.